ebomi
Colour theme
Sign in
Insider · CIK 0001632384

Galante Joseph C

CIK 0001632384 Name as filed on the most recent filing

Filed as Galante Joseph C (30)

465 transaction lines · from 30 filings · filed 2015-02-11 to 2023-01-23 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

465 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2020-10-26 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 227, acquired Open Form 4 filing 0001209191-21-008231
2020-08-26 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 740, acquired Open Form 4 filing 0001209191-20-048659
2020-08-21 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 1,256, acquired Open Form 4 filing 0001209191-20-048659
2020-08-14 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 1,290, acquired Open Form 4 filing 0001209191-20-048659
2020-08-07 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 1,283, acquired Open Form 4 filing 0001209191-20-048659
2020-07-31 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 1,223, acquired Open Form 4 filing 0001209191-20-048659
2020-07-24 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 1,249, acquired Open Form 4 filing 0001209191-20-048659
2020-07-17 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 1,234, acquired Open Form 4 filing 0001209191-20-048659
2020-07-10 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 1,241, acquired Open Form 4 filing 0001209191-20-048659
2020-07-02 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 1,002, acquired Open Form 4 filing 0001209191-20-048659
2020-06-26 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 1,264, acquired Open Form 4 filing 0001209191-20-048659
2020-06-19 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 1,279, acquired Open Form 4 filing 0001209191-20-048659
2020-06-12 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 758, acquired Open Form 4 filing 0001209191-20-048659
2020-06-09 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 261, acquired Open Form 4 filing 0001209191-20-036360
2020-06-08 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 266, acquired Open Form 4 filing 0001209191-20-036360
2020-06-05 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 258, acquired Open Form 4 filing 0001209191-20-036360
2020-06-04 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 248, acquired Open Form 4 filing 0001209191-20-036360
2020-06-03 P, Open-market purchase Pinnacle Financial Partners IncPNFP 100,000, acquired Open Form 4 filing 0001567619-20-011755
2020-06-03 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 247, acquired Open Form 4 filing 0001209191-20-036360
2020-06-02 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 251, acquired Open Form 4 filing 0001209191-20-036360
2020-06-01 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 259, acquired Open Form 4 filing 0001209191-20-036360
2020-05-29 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 251, acquired Open Form 4 filing 0001209191-20-036360
2020-05-28 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 251, acquired Open Form 4 filing 0001209191-20-036360
2020-05-27 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 262, acquired Open Form 4 filing 0001209191-20-036360
2020-05-26 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 269, acquired Open Form 4 filing 0001209191-20-036360
2020-05-22 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 271, acquired Open Form 4 filing 0001209191-20-036360
2020-05-21 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 276, acquired Open Form 4 filing 0001209191-20-036360
2020-05-20 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 283, acquired Open Form 4 filing 0001209191-20-036360
2020-05-19 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 284, acquired Open Form 4 filing 0001209191-20-036360
2020-05-18 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 287, acquired Open Form 4 filing 0001209191-20-036360
2020-05-15 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 282, acquired Open Form 4 filing 0001209191-20-036360
2020-05-14 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 286, acquired Open Form 4 filing 0001209191-20-036360
2020-05-13 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 590, acquired Open Form 4 filing 0001209191-20-036360
2020-05-11 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 603, acquired Open Form 4 filing 0001209191-20-036360
2020-05-07 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 596, acquired Open Form 4 filing 0001209191-20-036360
2020-05-05 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 599, acquired Open Form 4 filing 0001209191-20-036360
2020-05-01 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 602, acquired Open Form 4 filing 0001209191-20-036360
2020-04-29 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 602, acquired Open Form 4 filing 0001209191-20-036360
2020-04-27 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 603, acquired Open Form 4 filing 0001209191-20-036360
2020-04-23 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 605, acquired Open Form 4 filing 0001209191-20-036360
2020-04-21 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 605, acquired Open Form 4 filing 0001209191-20-036360
2020-04-17 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 606, acquired Open Form 4 filing 0001209191-20-036360
2020-04-15 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 608, acquired Open Form 4 filing 0001209191-20-036360
2020-04-13 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 302, acquired Open Form 4 filing 0001209191-20-036360
2020-02-28 P, Open-market purchase Pinnacle Financial Partners IncPNFP 78,375, acquired Open Form 4 filing 0001567619-20-005309
2019-10-18 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 185, acquired Open Form 4 filing 0001209191-19-054164
2019-10-17 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 331, acquired Open Form 4 filing 0001209191-19-054164
2019-10-16 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 334, acquired Open Form 4 filing 0001209191-19-054164
2019-10-15 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 338, acquired Open Form 4 filing 0001209191-19-054164
2019-10-14 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 340, acquired Open Form 4 filing 0001209191-19-054164

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 464
  • Open-market sale 1
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Galante Joseph C, insider transactions. Retrieved 2026-08-27 from https://ebomi.com/insider/0001632384

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.